Latest News and Press Releases

Eledon to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at WTC

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at WTC 2025

Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplantation Market by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast to 2030" report has been added to ...

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic...

Dublin, April 11, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplant Diagnostics Market - A Global and Regional Analysis: Focus on Offering, Application, Technology, Transplant Type, End User, and...

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Announces Tegoprubart Use as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals to Participate in Guggenheim SMID Cap Biotech Conference